The FDA has criticised the government’s decision to delay the implementation of reforms to the performance management system for Senior Civil Servants (SCS), and the announcement that the existing performance management policy, with some adjustments, will apply for 2022/23. The adjustments will see those at SCS level ranked in one of four categories, with an expectation that 5% of staff will be ranked in the lowest category.
As reported by Civil Service World, FDA Assistant General Secretary Lucille Thirlby described the updated guidance as “a retrograde and unnecessary step”, adding that “it is hard to comprehend why any organisation would arbitrarily decide that 5% of its staff must be underperforming”.
In a message to FDA members in the Senior Civil Service, Thirlby further expressed her disappointment at the decision, and added that the FDA had made further representations to the Senior Salaries Review Body, making clear the union’s unhappiness at the approach:
“It is disappointing that all the work the Cabinet Office has undertaken to change and improve the Performance Management system will not be realised for another year.”
If Prime Minister Andy Burnham wants a different political culture, he needs to start with the Ministerial Code says Dave Penman.
After comparing the results of our recent carers’ survey with our findings from 2020, Amelia Dowler shares the positives as well as the FDA’s recommendations to help carers within their civil service careers.
Tommy Newell speaks to Permanent Secretary to the Scottish Government Joe Griffin about leading an organisation through contraction, working with unions to shape change, and the promise of AI to make public services more human.
